Public Company News

Banyan Group Enters the United States with Banyan Tree Residences West Palm Beach

Developed in collaboration with Mast Capital and Curated JCZM Development, the project marks the U.S. debut of Banyan Group's flagship Banyan Tree brand  through its first residential offering in one of the country's fastest-evolving real estate markets. Banyan Tree Residences West Palm Beach WE...

2026-03-25 01:00 4957

Sands China Celebrates Grand Opening at Hong Kong's Art Central

Sands Gallery as bridge bringing Macao artists onto international art stage Contemporary artworks presented alongside century-old firecracker history  Showcasing vibrant energy of Macao's art and cultural scene MACAO, March 24, 2026 /PRNewswire/ -- Sands China celebrated the grand opening of its S...

2026-03-24 23:55 6342

Fosun Pharma Announces 2025 Annual Results

Innovation and Globalization Propel Fosun Pharma's High-Quality Growth SHANGHAI, March 24, 2026 /PRNewswire/ -- On 24 March, 2026, Fosun Pharma ("the company", stock code: 600196.SH; 02196.HK), an innovation-driven global pharmaceutical and healthcare group, announced its 2025 annual operating r...

2026-03-24 22:47 5424

Datasea (NASDAQ: DTSS) Announces Initial U.S. Commercial Rollout and Commercialization Pathway for Acoustic Technology-Enabled Wellness Care Robots

Early-stage deployments across multiple U.S. regions expected to support initial service revenue generation and scalable commercialization model BEIJING, March 24, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company specializing in acoustic high-te...

2026-03-24 21:30 5817

NYSE Content Update: The Hill & Valley Forum Convenes Leaders in Washington

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, March 24, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begi...

2026-03-24 21:19 4596

ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care

* Expanded treatment and visualization capabilities within posterior care workflows: ICGA for ZEISS CLARUS 700 offers FA + ICG simultaneous capture to help support clinical assessment and streamline the diagnostic process; ZEISS VISULAS green, now available with ZEISS SLT, offers dependable ret...

2026-03-24 21:00 4196

E-Home Household Services Holdings Limited has recently won bids for several community service centers, with the total value of the newly added services amounting to approximately 5 million RMB

FUZHOU, China, March 24, 2026 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider in China, announced today that the new spring company has signed domestic cleaning service agreements with multiple community heal...

2026-03-24 21:00 4338

Ping An Good Doctor Reports 2025 Annual Results: Corporate Health Management Business Posts Strong Growth; AI Healthcare Deployment Accelerates

HONG KONG, March 24, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or the "Company"; Stock Code: 1833.HK) announced its annual results for the year ended December 31, 2025. In 2025, the Company recorded total revenue of RMB5.47 billion, up 13.7% yea...

2026-03-24 20:37 5202

Erayak Power Solution Strategic Update: Accelerating High-Capacity UPS-Integrated Platforms to Support AI-Driven Energy Demand

Prototype preview expected at the 2026 National Hardware Show as Ruike Electronics facility advances WENZHOU, China, March 24, 2026 /PRNewswire/ -- Erayak Power Solution Group Inc. (Nasdaq: RAYA) ("Erayak" or the "Company"), a developer and manufacturer of portable power equipment, today announc...

2026-03-24 20:05 4851

WuXi Biologics Reports Record 2025 Annual Results

* Revenue increased 16.7% YoY to RMB 21.8 billion, and revenue from continuous operations grew over 20% YoY * IFRS gross profit margin expanded to 46.0% (+500 bps YoY); adjusted gross profit margin increased to 48.8% (+340bps) * EBITDA rose 38.1% YoY and IFRS net profit increased 45.3% YoY; ...

2026-03-24 19:44 5618

Nexteer Reports 2025 Year End Results

Continues Above-Market Growth with Expanding Margins AUBURN HILLS, Mich., March 24, 2026 /PRNewswire/ -- Nexteer Automotive (HK 1316) today reported financial results for the full year ended December 31, 2025, delivering record revenue, improved profitability and strong bookings momentum in supp...

2026-03-24 19:30 6222

Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer

Appointments Reinforce Deep Technical Expertise in Biotech R&D and Capital Markets Leadership as Origin Advances Its Commercial Pipeline BEIJING, March 24, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, tod...

2026-03-24 19:30 3598

LightInTheBox Reports Fourth Quarter and Full Year 2025 Financial Results

Record Full year Profit of $8.3 million Record Quarterly Profit of $3.3 Million Delivers Seventh Consecutive Profitable Quarter Regains Quarterly Revenue Growth SINGAPORE, March 24, 2026 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global consu...

2026-03-24 19:00 7329

Robo.ai Initiates Revenue Recognition for Intelligent Data Business and Advances Tens of Thousands of Hours of Capacity Cooperation Across the Middle East and Asia

DUBAI, UAE, March 24, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO) (the "Company" or "Robo.ai") today announced the capacity expansion plan for its intelligent data business segment. Following the delivery of its initial batch of real-world interaction data and the initiation of the revenue r...

2026-03-24 18:57 4513

Insilico Medicine and ASKA Pharmaceutical Expand Partnership to Discover Novel Targets for Women's Health

CAMBRIDGE, Mass., March 24, 2026 /PRNewswire/ -- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced a strategic research collaboration with ASKA Pharmaceutical Co., Ltd. ("ASKA"), a specialized p...

2026-03-24 18:29 4145

Tongcheng Travel Revenue Reaches 19.4 Billion in 2025

Leveraging the Mass Travel Market for Steady Performance Growth Embracing AI for High-Quality Development HONG KONG, March 24, 2026 /PRNewswire/ -- Tongcheng Travel Holdings Limited ("Tongcheng Travel" or the "Company", together with its subsidiaries the "Group", stock code: 0780.HK), a leading c...

2026-03-24 17:41 4452

GCCL Showcases RSV FRNT Research and Integrated Bioanalytical Capabilities at World Vaccine Congress 2026

YONGIN, South Korea, March 24, 2026 /PRNewswire/ -- GCCL Co., Ltd. (GCCL), a global clinical trial laboratory services provider, announced that it will attend World Vaccine Congress 2026 (WVC 2026), taking place from March 30 to April 2 in Washington, D.C., where it will operate an exhibition boo...

2026-03-24 17:35 3732

Kelun-Biotech Receives IND Approval for SKB103, a Novel TAA-PD-L1 Bispecific ADC

CHENGDU, China, March 24, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that the Investigational New Drug (IND) application for SKB103, its self-developed novel bispecific antibody-drug conjugate with combined T...

2026-03-24 17:24 4857

Cheetah Mobile Announces Fourth Quarter and Fiscal Year 2025 Unaudited Consolidated Financial Results

AI and Others revenue grew 84.7% year over year and accounted for 46.5% of total revenue in 2025 BEIJING, March 24, 2026 /PRNewswire/ -- Cheetah Mobile Inc. ("Cheetah Mobile" or the "Company") (NYSE: CMCM), a China-based IT company with a commitment to AI innovation, today announced its unaudite...

2026-03-24 16:30 5208

DualityBio (9606.HK) Announces 2025 Annual Results

HONG KONG, March 24, 2026 /PRNewswire/ -- Duality Biotherapeutics, Inc. (Hong Kong Stock Exchange Code: 09606.HK, hereinafter referred to as "DualityBio" or the "Company"), a leading global clinical-stage innovative biopharmaceutical company, today announced its first annual results since listing...

2026-03-24 15:55 5429